281 related articles for article (PubMed ID: 29171279)
1. Dietary Supplement Adverse Event Report Data From the FDA Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS), 2004-2013.
Timbo BB; Chirtel SJ; Ihrie J; Oladipo T; Velez-Suarez L; Brewer V; Mozersky R
Ann Pharmacother; 2018 May; 52(5):431-438. PubMed ID: 29171279
[TBL] [Abstract][Full Text] [Related]
2. Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems.
Raschi E; Girardi A; Poluzzi E; Forcesi E; Menniti-Ippolito F; Mazzanti G; De Ponti F
Drug Saf; 2018 Aug; 41(8):745-752. PubMed ID: 29582393
[TBL] [Abstract][Full Text] [Related]
3. Application of FDA adverse event report data to the surveillance of dietary botanical supplements.
Wallace RB; Gryzlak BM; Zimmerman MB; Nisly NL
Ann Pharmacother; 2008 May; 42(5):653-60. PubMed ID: 18397972
[TBL] [Abstract][Full Text] [Related]
4. Caffeinated energy drinks: adverse event reports to the US Food and Drug Administration and the National Poison Data System, 2008 to 2015.
Markon AO; Jones OE; Punzalan CM; Lurie P; Wolpert B
Public Health Nutr; 2019 Oct; 22(14):2531-2542. PubMed ID: 31317857
[TBL] [Abstract][Full Text] [Related]
5. Detecting Signals of Dietary Supplement Adverse Events from the CFSAN Adverse Event Reporting System (CAERS).
Vasilakes JA; Rizvi RF; Zhang J; Adam TJ; Zhang R
AMIA Jt Summits Transl Sci Proc; 2019; 2019():258-266. PubMed ID: 31258978
[TBL] [Abstract][Full Text] [Related]
6. Serious Adverse Events Reported with Dietary Supplement Use in the United States: A 2.5 Year Experience.
Schmitz SM; Lopez HL; Mackay D; Nguyen H; Miller PE
J Diet Suppl; 2020; 17(2):227-248. PubMed ID: 30513022
[TBL] [Abstract][Full Text] [Related]
7. Narrative Review: The FDA's Perfunctory Approach of Dietary Supplement Regulations Giving Rise to Copious Reports of Adverse Events.
Li W; Wertheimer A
Innov Pharm; 2023; 14(1):. PubMed ID: 38035313
[No Abstract] [Full Text] [Related]
8. Dietary supplement adverse event reports: review and analysis.
Talati AR; Gurnani AK
Food Drug Law J; 2009; 64(3):503-13. PubMed ID: 19999641
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the FDA adverse event reporting system and the potential for reporting bias.
Monnot AD; Fung ES; Compoginis GS; Towle KM
J Cosmet Dermatol; 2021 Jun; 20(6):1849-1854. PubMed ID: 33713536
[TBL] [Abstract][Full Text] [Related]
10. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
Frankos VH; Street DA; O'Neill RK
Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
[TBL] [Abstract][Full Text] [Related]
11. The state of dietary supplement adverse event reporting in the United States.
Gardiner P; Sarma DN; Low Dog T; Barrett ML; Chavez ML; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260
[TBL] [Abstract][Full Text] [Related]
12. Adverse Events Reported to the United States Food and Drug Administration Related to Caffeine-Containing Products.
Jagim AR; Harty PS; Fischer KM; Kerksick CM; Erickson JL
Mayo Clin Proc; 2020 Aug; 95(8):1594-1603. PubMed ID: 32753134
[TBL] [Abstract][Full Text] [Related]
13. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
14. Nutravigilance: principles and practices to enhance adverse event reporting in the dietary supplement and natural products industry.
Schmitz SM; Lopez HL; MacKay D
Int J Food Sci Nutr; 2014 Mar; 65(2):129-34. PubMed ID: 24112316
[TBL] [Abstract][Full Text] [Related]
15. Dietary supplement adverse events: report of a one-year poison center surveillance project.
Haller C; Kearney T; Bent S; Ko R; Benowitz N; Olson K
J Med Toxicol; 2008 Jun; 4(2):84-92. PubMed ID: 18570167
[TBL] [Abstract][Full Text] [Related]
16. The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement.
Klontz KC; DeBeck HJ; LeBlanc P; Mogen KM; Wolpert BJ; Sabo JL; Salter M; Seelman SL; Lance SE; Monahan C; Steigman DS; Gensheimer K
Public Health Rep; 2015; 130(5):526-32. PubMed ID: 26327730
[TBL] [Abstract][Full Text] [Related]
17. Everyday Evaluation of Herb/Dietary Supplement-Drug Interaction: A Pilot Study.
Souza-Peres JV; Flores K; Umloff B; Heinan M; Herscu P; Babos MB
Medicines (Basel); 2023 Feb; 10(3):. PubMed ID: 36976309
[TBL] [Abstract][Full Text] [Related]
18. Physicians' understanding of the regulation of dietary supplements.
Ashar BH; Rice TN; Sisson SD
Arch Intern Med; 2007 May; 167(9):966-9. PubMed ID: 17502539
[TBL] [Abstract][Full Text] [Related]
19. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
[TBL] [Abstract][Full Text] [Related]
20. Patient use of dietary supplements: a clinician's perspective.
Sadovsky R; Collins N; Tighe AP; Brunton SA; Safeer R
Curr Med Res Opin; 2008 Apr; 24(4):1209-16. PubMed ID: 18348745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
